Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Showing 20 of 0 results

Not applicableStudy completedNCT00312598
What this trial is testing

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
University of North Carolina, Chapel Hill 30
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Large-scale testing (Phase 3)Study completedNCT02751632
What this trial is testing

The Staged Treatment in Early Psychosis Study

Who this might be right for
Psychotic DisordersPersonality DisordersClinical High Risk
Orygen 342
Not applicableLooking for participantsNCT06194344
What this trial is testing

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Who this might be right for
Psychosis
The University of Texas Health Science Center, Houston 40
Not applicableStudy completedNCT03056781
What this trial is testing

Emotional Response in Psychiatric and Control Participants

Who this might be right for
SchizophreniaEmotions
University of California, Irvine 46
Not applicableStudy completedNCT00207064
What this trial is testing

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 46
Not applicableStudy completedNCT02192593
What this trial is testing

Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Boston University Charles River Campus 45
Not applicableActive Not RecruitingNCT05112432
What this trial is testing

EPI-MINN: Targeting Cognition and Motivation

Who this might be right for
Psychosis
University of Minnesota 400
Early research (Phase 1)Study completedNCT00888693
What this trial is testing

A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 81
Large-scale testing (Phase 3)Study completedNCT00731549
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,081
Not applicableStudy completedNCT01355952
What this trial is testing

An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia

Who this might be right for
ObesityWeight LossSchizophrenia
Yale University 17
Post-approval studies (Phase 4)Study completedNCT00784238
What this trial is testing

Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 289
Not applicableUnknownNCT05310955
What this trial is testing

Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 60
Post-approval studies (Phase 4)UnknownNCT06501339
What this trial is testing

Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia

Who this might be right for
Clozapine Resistant Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 40
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Not applicableEnded earlyNCT00211302
What this trial is testing

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Louisiana State University Health Sciences Center Shreveport 8
Early research (Phase 1)Study completedNCT02019329
What this trial is testing

The Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

Who this might be right for
Schizophrenia
Hoffmann-La Roche 32
Not applicableStudy completedNCT02538445
What this trial is testing

Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia

Who this might be right for
Schizophrenia
Centre Hospitalier Universitaire de Saint Etienne 96
Testing effectiveness (Phase 2)Study completedNCT00963846
What this trial is testing

Huperzine for Cognitive and Functional Impairment in Schizophrenia

Who this might be right for
Schizophrenia
Biomedisyn Corporation 56
Early research (Phase 1)Study completedNCT00743405
What this trial is testing

Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

Who this might be right for
Cognitive Disorders
GlaxoSmithKline 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation